The chemical scaffolds from which screening libraries are built have strong influence on the libraries' utility for screening campaigns. Here we present analysis of the scaffold composition of several types of commercially available screening collections and compare those compositions to those of drugs and drug candidates.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bortezomib-induced neuropathy is in part mediated by the sensitization of TRPV1 channels
Communications Biology Open Access 05 December 2023
-
Manipulations of phenylnorbornyl palladium species for multicomponent construction of a bridged polycyclic privileged scaffold
Communications Chemistry Open Access 29 October 2022
-
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets
Structural Chemistry Open Access 11 February 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Miller, J.L. Curr. Top. Med. Chem. 6, 19–29 (2006).
Bissantz, C., Schalon, C., Guba, W. & Stahl, M. Proteins 61, 938–952 (2005).
Fitzgerald, S.H., Sabat, M. & Geysen, H.M. J. Chem. Inf. Model. 46, 1588–1597 (2006).
Truchon, J.F. & Bayly, C.I. J. Chem. Inf. Model. 46, 1536–1548 (2006).
Costantino, L. & Barlocco, D. Curr. Med. Chem. 13, 65–85 (2006).
DeSimone, R.W., Currie, K.S., Mitchell, S.A., Darrow, J.W. & Pippin, D.A. Comb. Chem. High Throughput Screen. 7, 473–494 (2004).
Muller, G. Drug Discov.Today 8, 681–691 (2003).
Burke, M.D. & Schreiber, S.L. Angew. Chem. Int. Edn Engl. 43, 46–58 (2004).
Khersonsky, S.M. & Chang, Y.T. Comb. Chem. High Throughput Screen. 7, 645–652 (2004).
Tan, D.S. Nat. Chem. Biol. 1, 74–84 (2005).
Evans, B.E. et al. J. Med. Chem. 31, 2235–2246 (1988).
Dekker, F.J., Koch, M.A. & Waldmann, H. Curr. Opin. Chem. Biol. 9, 232–239 (2005).
Kingston, D.G. & Newman, D.J. IDrugs 8, 990–992 (2005).
Bemis, G.W. & Murcko, M.A. J. Med. Chem. 39, 2887–2893 (1996).
Xu, Y.J. & Johnson, M. J. Chem. Inf. Comput. Sci. 42, 912–926 (2002).
Broughton, H.B. & Watson, I.A. J. Mol. Graph. Model. 23, 51–58 (2004).
Ertl, P., Jelfs, S., Muhlbacher, J., Schuffenhauer, A. & Selzer, P. J. Med. Chem. 49, 4568–4573 (2006).
Schuffenhauer, A. et al. J. Chem. Inf. Model. 47, 47–58 (2007).
Wilkens, S.J., Janes, J. & Su, A.I. J. Med. Chem. 48, 3182–3193 (2005).
Koch, M.A. et al. Proc. Natl. Acad. Sci. USA 102, 17272–17277 (2005).
Shannon, P. et al. Genome Res. 13, 2498–2504 (2003).
Willett, P. Drug Discov. Today 11, 1046–1053 (2006).
Goess, B.C., Hannoush, R.N., Chan, L.K., Kirchhausen, T. & Shair, M.D. J. Am. Chem. Soc. 128, 5391–5403 (2006).
Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Oprea, T.I. J. Comput. Aided Mol. Des. 14, 251–264 (2000).
Rishton, G.M. Drug Discov. Today 2, 382–384 (1997).
Congreve, M., Carr, R., Murray, C. & Jhoti, H. Drug Discov.Today 8, 876–877 (2003).
Hartshorn, M.J. et al. J. Med. Chem. 48, 403–413 (2005).
Newman, D.J., Cragg, G.M. & Snader, K.M. J. Nat. Prod. 66, 1022–1037 (2003).
Bonchev, D. & Buck, G.A. J. Chem. Inf. Model. 47, 909–917 (2007).
Beeler, A.B. et al. J. Comb. Chem. 7, 673–681 (2005).
Lei, X., Zaarur, N., Sherman, M.Y. & Porco, J.A. Jr. J. Org. Chem. 70, 6474–6483 (2005).
Burke, M.D., Berger, E.M. & Schreiber, S.L. J. Am. Chem. Soc. 126, 14095–14104 (2004).
Pelish, H.E., Westwood, N.J., Feng, Y., Kirchhausen, T. & Shair, M.D. J. Am. Chem. Soc. 123, 6740–6741 (2001).
Acknowledgements
This work was supported by the American Lebanese Syrian Associated Charities (ALSAC) and St. Jude Children's Research Hospital (SJCRH).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Shelat, A., Guy, R. Scaffold composition and biological relevance of screening libraries. Nat Chem Biol 3, 442–446 (2007). https://doi.org/10.1038/nchembio0807-442
Issue Date:
DOI: https://doi.org/10.1038/nchembio0807-442
This article is cited by
-
Bortezomib-induced neuropathy is in part mediated by the sensitization of TRPV1 channels
Communications Biology (2023)
-
Ni-catalyzed ligand-controlled divergent and selective synthesis
Science China Chemistry (2023)
-
Manipulations of phenylnorbornyl palladium species for multicomponent construction of a bridged polycyclic privileged scaffold
Communications Chemistry (2022)
-
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets
Structural Chemistry (2022)
-
Understanding the diversity of the metal-organic framework ecosystem
Nature Communications (2020)